Combined company will have annual revenues of about $11bn
OrphanReach alliance will see companies provide product lifecycle services
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
Supports marketing applications from Takeda and Lundbeck
Drugs (Prices Control) Order 2013 reduces price of hundreds of drugs
Report says research site can remain open with minimal job losses
Agency investigation concludes acne treatment's benefits outweigh its risks
Programme recognises responsible marketing and business practice in the healthcare industry
Adds to rheumatoid arthritis, psoriatic arthritis and active ankylosing spondylitis indications in the US
Chasing the cure for Parkinson’s diseaseResearch for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
From paralysis to analysis: the journey to multichannel marketingTo make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
Bringing trial data out of the shadowsTransparency of clinical trial data has become a hotly disputed topic recently, how the industry at large will respond is still not clear, but as the noise grows louder, reputations
Sanofi plans to file JAK2 inhibitor after positive phase IIIAiming for approval in blood cancer myelofibrosis
Bayer boosts consumer care business with Steigerwald purchaseFuels ambition to become world leader in OTC medicines
NICE recommends Astellas' Betmiga for overactive bladderFinal draft guidance recommends Vesicare successor
Atlas Venture fund aims to create 15 new biotech companies
Merck KGaA forges clinical alliance with QuintilesCRO becomes sole outsourcing partner for pharma company
FDA clears Bayer/ Algeta's prostate cancer radiotherapyApproval for Xofigo comes three months ahead of schedule
Video for neglected tropical diseases challenges viewersNon-profit organisation END7 asks: 'Can you watch what they watched?'
Boehringer's Wolfram Carius to step downHe will be replaced by Wolfgang Baiker on the board of managing directors
Canada role for UCB's Hervé Lilliu Appointed general manager of biopharma company’s operations in the country
Former NICE chair joins board of biotechSir Michael Rawlins joins board of Intra-Cellular Therapeutics
Lundbeck's Steve Turley re-elected as EMG chairAnd Actelion's Robin Bhattacherjee retains vice-chair position
VC firm expands team, appoints Genzyme and Lilly veteransNew roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore
'We have a habit of divine discontent with our performance.It is an antidote to smugness.'So said David Ogilvy. ...